Tempus Capital Inc. (CSE: TEMP) and TUK Group Close New Toronto Development Project With Additional Sites Under Contract

About Tempus Capital Inc. Tempus Capital Inc. is a Canadian real estate company engaged in the acquisition, development and ownership of income-generating properties. Tempus trades on the Canadian ...
Business Wire

Tempus Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to develop a ...
TMCnet

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the publication of a new study in JCO Precision Oncology highlighting how ...

Tempus Capital Inc.: Tempus Capital Announces Joint Development Project in Toronto with TUK Group

Tempus Capital Inc. (CSE: TEMP) ("Tempus" or the "Company") is pleased to announce it has signed a joint development with TUK Group for a new ...
Nasdaq

Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer

Tempus Next supports providers in closing gaps in care for eligible patients based on clinical guidelines. “Staying current with rapidly evolving clinical guidelines—especially regarding biomarker ...